On June 21, 2022, Shiseido Company, Limited (Headquarters: Chuo-ku, Tokyo; President and CEO: Masahiko Uotani; hereinafter "Shiseido") signed a comprehensive collaboration agreement with the Institute for Advanced Biosciences, Keio University (Tsuruoka City, Yamagata Prefecture; Director General: Masaru Tomita; hereinafter "IAB"), for the purpose of fostering talented individuals who will lead future innovation.

Under the agreement, Shiseido and IAB will work together, supporting researchers in identifying issues within their research fields, and create future innovations through unprecedented research approaches and exchanges between experts. In the long run, the goal is to develop new leaders going beyond the conventional frameworks in the R＆D field.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Shiseido Co. Ltd. published this content on 21 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 June 2022 04:53:06 UTC.